Active ingredients Isorhamnetin of Croci Srigma inhibit stomach adenocarcinomas progression by MAPK/mTOR signaling pathway | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Active ingredients Isorhamnetin of Croci Srigma inhibit stomach adenocarcinomas progression by MAPK/mTOR signaling pathway

Authors:: Xue-feng Shi; Qi Yu; Kai-bo Wang; Yi-dong Fu; Shun Zhang; Zhen-yun Liao; Yan Li; Ting Cai

Reference:: Scientific Reports; 2023; 13; 12607

DOI:: 10.1038/s41598-023-39627-z

See Abstract

Key Words:: Croci srigma; isorhamnetin; stomach adenocarcinoma; target gene; MAPK14; HGC-27; MAPK/mTOR

Back to index